dr. martens plc - DOCMF

DOCMF

Close Chg Chg %
0.88 -0.02 -1.80%

Open Market

0.86

-0.02 (1.80%)

Volume: 5.00K

Last Updated:

May 11, 2026, 12:40 PM EDT

Company Overview: dr. martens plc - DOCMF

DOCMF Key Data

Open

$0.86

Day Range

0.86 - 0.86

52 Week Range

0.76 - 1.36

Market Cap

$831.79M

Shares Outstanding

967.19M

Public Float

568.43M

Beta

0.87

Rev. Per Employee

N/A

P/E Ratio

44.25

EPS

N/A

Yield

382.51%

Dividend

$0.01

EX-DIVIDEND DATE

Mar 5, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

2.58K

 

DOCMF Performance

1 Week
 
1.52%
 
1 Month
 
-2.11%
 
3 Months
 
-7.89%
 
1 Year
 
24.48%
 
5 Years
 
N/A
 

DOCMF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About dr. martens plc - DOCMF

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

DOCMF At a Glance

Dr. Martens Plc
28 Jamestown Road
London, Greater London NW1 7BY
Phone 44-121-415-7047 Revenue 1.00B
Industry Apparel/Footwear Net Income 5.74M
Sector Consumer Non-Durables Employees 2,348
Fiscal Year-end 03 / 2026
View SEC Filings

DOCMF Valuation

P/E Current 44.251
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 112.08
Price to Sales Ratio 0.652
Price to Book Ratio 1.37
Price to Cash Flow Ratio 3.05
Enterprise Value to EBITDA 5.718
Enterprise Value to Sales 0.968
Total Debt to Enterprise Value 0.533

DOCMF Efficiency

Revenue/Employee 427,903.461
Income Per Employee 2,444.852
Receivables Turnover 12.761
Total Asset Turnover 0.854

DOCMF Liquidity

Current Ratio 2.591
Quick Ratio 1.409
Cash Ratio 0.983

DOCMF Profitability

Gross Margin 55.739
Operating Margin 7.694
Pretax Margin 1.117
Net Margin 0.571
Return on Assets 0.488
Return on Equity 1.224
Return on Total Capital 0.579
Return on Invested Capital 0.595

DOCMF Capital Structure

Total Debt to Total Equity 109.634
Total Debt to Total Capital 52.298
Total Debt to Total Assets 45.145
Long-Term Debt to Equity 97.107
Long-Term Debt to Total Capital 46.322
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DOCMF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.24B 1.20B 1.10B 1.00B
Sales Growth
+22.93% -2.94% -8.51% -8.80%
Cost of Goods Sold (COGS) incl D&A
500.19M 525.32M 470.00M 444.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
50.13M 65.24M 90.81M 92.74M
Depreciation
43.71M 55.13M 83.53M 84.96M
Amortization of Intangibles
6.42M 10.11M 7.28M 7.78M
COGS Growth
+13.89% +5.02% -10.53% -5.38%
Gross Income
740.45M 678.80M 631.65M 560.02M
Gross Income Growth
+29.90% -8.33% -6.95% -11.34%
Gross Profit Margin
+59.68% +56.37% +57.34% +55.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
422.61M 449.12M 472.89M 482.71M
Research & Development
- - - -
-
Other SG&A
422.61M 449.12M 472.89M 482.71M
SGA Growth
+35.61% +6.27% +5.29% +2.08%
Other Operating Expense
- - - -
-
Unusual Expense
- 273.18K 4.69M 26.28M
EBIT after Unusual Expense
317.57M 224.98M 158.76M 51.03M
Non Operating Income/Expense
(4.37M) (10.59M) (1.51M) 765.40K
Non-Operating Interest Income
- 2.29M 3.77M 4.85M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
20.49M 22.51M 40.44M 40.57M
Interest Expense Growth
-62.28% +9.87% +79.67% +0.30%
Gross Interest Expense
20.49M 22.51M 40.44M 40.57M
Interest Capitalized
- - - -
-
Pretax Income
292.71M 191.88M 116.81M 11.23M
Pretax Income Growth
+216.22% -34.45% -39.12% -90.39%
Pretax Margin
+23.59% +15.94% +10.60% +1.12%
Income Tax
45.21M 36.71M 29.89M 5.49M
Income Tax - Current - Domestic
42.62M 31.78M 20.85M 2.04M
Income Tax - Current - Foreign
5.87M 5.18M 8.04M 4.85M
Income Tax - Deferred - Domestic
(3.28M) (240.75K) 1.00M (1.40M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
247.50M 155.16M 86.92M 5.74M
Minority Interest Expense
- - - -
-
Net Income
247.50M 155.16M 86.92M 5.74M
Net Income Growth
+431.01% -37.31% -43.98% -93.40%
Net Margin Growth
+19.95% +12.89% +7.89% +0.57%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
247.50M 155.16M 86.92M 5.74M
Preferred Dividends
- - - -
-
Net Income Available to Common
247.50M 155.16M 86.92M 5.74M
EPS (Basic)
0.2475 0.1551 0.0884 0.006
EPS (Basic) Growth
+431.12% -37.33% -43.00% -93.21%
Basic Shares Outstanding
1.00B 1.00B 983.50M 962.30M
EPS (Diluted)
0.2468 0.155 0.0882 0.0059
EPS (Diluted) Growth
+429.61% -37.20% -43.10% -93.31%
Diluted Shares Outstanding
1.00B 1.00B 985.60M 974.10M
EBITDA
367.97M 294.92M 249.57M 170.05M
EBITDA Growth
+21.59% -19.85% -15.38% -31.86%
EBITDA Margin
+29.66% +24.49% +22.65% +16.92%

Dr. Martens Plc in the News